Veterinary Drugs Market 2028 By Product, Route of Administration, End User and Geography | The Insight Partners

report image

Veterinary Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Anti-Infective Drugs, Anti-Inflammatory Drugs, Parasiticides, Others); Route of Administration (Oral Route, Parenteral Route, Topical Route); End User (Veterinary Hospitals, Veterinary Clinics, Others) and Geography

Report Code: TIPRE00019341 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET INTRODUCTION

Veterinary drugs are termed as medications used to treat various medical conditions in animals. Veterinary drugs include anti-infective drugs, anti-inflammatory drugs, and parasiticides, which are administered orally in animals. Veterinary drugs are used in various animals, including companion animals such as dogs and cats and livestock animals such as cattle, pigs, and poultry. Moreover, the medicine is administered in animals via various routes such as oral route, parenteral route, and some parasiticidal drug preparations are administered through topical route.

MARKET DYNAMICS

The veterinary drugs market has shown a significant evolution over the forecast period. The rise of the veterinary drugs market is driven by the increase in the number of pet owners and the surge in livestock population worldwide. According to American Pet Products Association (APPA), 67% percent of United States households own a pet, and estimated that 78 million dogs and 85.8 million cats are owned in the United States. Furthermore, factors such as a surge in prevalence of various medical conditions in animals and a rise in demand for livestock products also boost the veterinary medicine market growth. Also, the rise in animal healthcare expenditure is another major factor that fuels the market's development. However, lack of veterinary infrastructure facilities in underdeveloped nations and stringent regulations associated with medicated feed additives restrict veterinary medicine market growth. Conversely, an increase in awareness toward animal health offers a lucrative opportunity for the veterinary medicine market.

MARKET SCOPE

The "Veterinary Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, focusing on the global market trend analysis. This report outlines the veterinary drugs market with detailed market segmentation by product, route of administration, and end-user. The veterinary drugs market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on leading players' market status in the veterinary drugs market and provides key opportunities and trends in the market.

MARKET SEGMENTATION

The market is categorized based on the product, route of administration, and end user. Based on the product, the market is segmented as anti-infective drugs, anti-inflammatory drugs, parasiticides, and others. Based on the route of administration, the segmentation of the market is into oral route, parenteral route, and topical route. Based on end user, the segmentation of the market is into veterinary hospitals, veterinary clinics, and others.

REGIONAL FRAMEWORK

The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the veterinary drugs market based on various segments. The report also consists of market size and forecast estimates from the year 2020 to2028with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The veterinary drugs market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.

The report analyzes factors affecting the veterinary drugs market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East, and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the Veterinary drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report contains critical developments in the veterinary drugs market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the veterinary drugs market are estimated to have profitable growth opportunities in the coming years with the higher demand for veterinary drugs in the global market. Given below is the list of a few companies engaged in the veterinary drugs market.

The report also offers key players' profiles in the veterinary drugs market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.

  •  Zoetis
  •  Boehringer Ingelheim International GmbH
  •  Bayer AG
  •  Eli Lilly and Company.
  •  Ceva
  •  Dechra Pharmaceuticals PLC.
  •  Intervet Inc. (Merck & Co. Inc.)
  •  Virbac.
  •  Vetoquinol S.A.
  •  Evonik Industries AG.

The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.


Get more information on this report :

The List of Companies

1.Zoetis
2.Boehringer Ingelheim International GmbH
3.Bayer AG
4.Eli Lilly and Company.
5.Ceva
6.Dechra Pharmaceuticals PLC.
7.Intervet Inc. (Merck & Co. Inc.)
8.Virbac.
9.Vetoquinol S.A.
10.Evonik Industries AG.
TIPRE00019341
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




tip-analyst

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount